National Breast Cancer Awareness Month (see related guidelines) 3 | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

• National Breast Cancer Awareness Month (see related guidelines)

• GUIDELINE SUMMARY
 
• NGC:008706
 
• 2010 OCT (REPUBLISHED 2012 JAN)

Magnetic resonance imaging for breast cancer screening, pre-operative assessment, and follow-up.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:011120
 
• 2016 NOV 20

Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ.

American Society for Radiation Oncology; American Society of Clinical Oncology; Society of Surgical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:010056
 
• 2002 JUL (REVISED 2013 NOV 19)

Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force

Related Guideline Synthesis: Pharmacologic Interventions for Breast Cancer Risk Reduction in Women

Compare

• GUIDELINE SUMMARY
 
• NGC:009229
 
• 1996 (REVISED 2012)

ACR Appropriateness Criteria® postmastectomy radiotherapy.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:011061
 
• 2016 SEP 1

Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:010222
 
• 2013 NOV 20

Comparison of Oncotype DX with multi-gene profiling assays (e.g., MammaPrint, PAM50) and other tests (e.g., Adjuvant! Online, Ki-67 and IHC4) in early-stage breast cancer.

Program in Evidence-based Care

Compare

• GUIDELINE SUMMARY
 
• NGC:009952
 
• 2004 MAY (REVISED 2013 JUN)

Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer.

National Guideline Alliance

Compare

• GUIDELINE SUMMARY
 
• NGC:010780
 
• 2015 AUG 20

Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology clinical practice guideline.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:010653
 
• 2014

ACR Appropriateness Criteria® evaluation of the symptomatic male breast.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:010539
 
• 2013 SEP

Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat.

National Institute for Health and Care Excellence (NICE)

Compare

• GUIDELINE SUMMARY
 
• NGC:010053
 
• 2012 SEP

Cancer and contraception.

Society of Family Planning

Compare

• GUIDELINE SUMMARY
 
• NGC:010372
 
• 2012 NOV

Bone health in patients with breast cancer.

CancerControl Alberta

Compare

• GUIDELINE SUMMARY
 
• NGC:009958
 
• 2007 OCT (REVISED 2013 JUN)

Common breast problems.

University of Michigan Health System

Compare

• GUIDELINE SUMMARY
 
• NGC:009371
 
• 1996 (REVISED 2013 JAN 1)

Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force

Compare

• GUIDELINE SUMMARY
 
• NGC:011204
 
• 2017

ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:011180
 
• 2017 FEB 10

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:011009
 
• 2016 JUL 10

Selection of optimal adjuvant chemotherapy regimens for human epidermal growth factor receptor 2 (HER2)-negative and adjuvant targeted therapy for HER2-positive breast cancers: an American Society of Clinical Oncology guideline adaptation of the Cancer Care Ontario clinical practice guideline.

American Society of Clinical Oncology

Compare

• GUIDELINE SUMMARY
 
• NGC:010674
 
• 1996 (REVISED 2014)

ACR Appropriateness Criteria® ductal carcinoma in situ.

American College of Radiology

Compare

• GUIDELINE SUMMARY
 
• NGC:008958
 
• 2012 MAR

Management of gynecologic issues in women with breast cancer.

American College of Obstetricians and Gynecologists

Compare

• GUIDELINE SUMMARY
 
• NGC:010823
 
• 2015 OCT 20

Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society.

American Cancer Society

Related Guideline Synthesis: Screening for Breast Cancer in Women at Average Risk

• GUIDELINE SUMMARY
 
• NGC:011165
 
• 2016 DEC 20

Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update.

American Society for Radiation Oncology; American Society of Clinical Oncology; Society of Surgical Oncology